Researchers sought to determine factors associated with mortality for patients with AML and hyperleukocytosis.

The study showed that having pre-existing leukopenia and more favorable performance status was associated with a higher risk ...

During my second trimester of pregnancy, I started to notice a weird rash, which led to other events before my diagnosis of ...

Researchers sought to determine whether complete remission with partial hematological recovery is beneficial in patients with AML.

“It’s characterized by a dry, itchy, and sometimes scaly rash that commonly appears on the face, the backs of the knees, and the wrists.” It can also show up on the neck, ankles, or in areas that bend ...

The Secondary Acute Myeloid Leukemia drugs in development market research report provides comprehensive information on the therapeutics under development for Secondary Acute Myeloid Leukemia, complete ...

Leukemia & Lymphoma Society. Blood transfusion. Arora PC, Arora A, Arora S. Oral manifestations as an early clinical sign of acute myeloid leukemia: A report of two cases. Indian J Dermatol.

People with Down syndrome face a higher risk of developing leukemia. Now researchers explain why, by identifying specific changes in blood cells of people with Down syndrome. People with Down ...

Acute myeloid leukemia (AML) is a malignant tumor of the hematological system. Because of its characteristics of recurrence, refractory and chemoresistance, new therapeutic targets need to be ...

NEW YORK — Because of their heterogeneity in appearance, drug-induced skin rashes are a common diagnostic challenge, but eruptions in skin of color, particularly those with a delayed onset ...

80% of patients with previously untreated or relapsed/refractory advanced-phase chronic myeloid leukemia (CML) – including both accelerated or myeloid blast phases of the disease – or Philadelphia ...

According to researchers at The University of Texas MD Anderson Cancer Center, 80% of patients with previously untreated or relapsed/refractory advanced-phase chronic myeloid leukemia (CML ...